BioKier
Pre-clinicalBioKier is a clinical-stage company developing oral products for the management of lipids and glucose that can be commercialized via 505(b)2 NDA path. These products are designed to mimic bariatric-metabolic surgery which is known to resolve diabetes and improve cardiometabolic health. Completed clinical trials show that BioKier’s approach improves gut hormone secretion and regulation of glucose and lipids.
About
BioKier is a clinical-stage company developing oral products for the management of lipids and glucose that can be commercialized via 505(b)2 NDA path. These products are designed to mimic bariatric-metabolic surgery which is known to resolve diabetes and improve cardiometabolic health. Completed clinical trials show that BioKier’s approach improves gut hormone secretion and regulation of glucose and lipids.
Funding History
12Total raised: $19.7M
Company Info
Contact
Sectors
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile